National Cancer Institute (NCI): all 3,554 studies

Page 22 of 36. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT01749397Phase 1
• Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT01749384Phase 1
• Biomarkers for Breast Cancer Risk in African American WomenCompletedNCT01736306
• Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell LymphomaCompletedNCT01729806Phase 1
• Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerCompletedNCT01727076Phase 1
• Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid TumorsCompletedNCT01725191Phase 1
• Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent NeuroblastomaActive, not recruitingNCT01711554Phase 1
• Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaCompletedNCT01711528Phase 1
• Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical CancerCompletedNCT01711515Phase 1
• Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryTerminatedNCT01705340Phase 1
• Relationship Stressors in Parents of Children With Cancer or Neurofibromatosis Type 1 (NF1)CompletedNCT01702922
• Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin LymphomaActive, not recruitingNCT01695941Phase 1
• GRN1005 for Brain Metastases From Breast or Lung CancerWithdrawnNCT01679743Phase 2
• Self-Affirmation and Response to Health Risk InformationCompletedNCT01668771
• Testing the FLASHE SurveyCompletedNCT01661036
• The Ghana Breast Health StudyCompletedNCT01661023
• MLN9708 and Dexamethasone for High-Risk Smoldering Multiple MyelomaWithdrawnNCT01660997Phase 2
• Natural History Study of Children and Adults With Medullary Thyroid CancerActive, not recruitingNCT01660984
• Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT01660971Phase 1
• Collecting Solid Tumor Tissue to Identify New TreatmentsCompletedNCT01658917
• Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT01654965Phase 1
• Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib MaintenanceWithdrawnNCT01647165Phase 2
• Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are MetastaticCompletedNCT01643278Phase 1
• Validating Pain Scales in Children and Young AdultsCompletedNCT01639950
• Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
• [18]F-Fluciclatide for Kidney Cancer Imaging Studies and TreatmentWithdrawnNCT01633255Phase 1/2
• Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic PainCompletedNCT01633008Early Phase 1
• Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaActive, not recruitingNCT01627041Phase 2
• Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by SurgeryCompletedNCT01625156Phase 1
• Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast CancerCompletedNCT01624441Phase 1
• 18F FLT Imaging Studies of Treatment Response for Lung Cancer and ThymomaWithdrawnNCT01610544Phase 2
• Vorinostat in Treating Patients With Metastatic Melanoma of the EyeActive, not recruitingNCT01587352Phase 2
• Vemurafenib and White Blood Cell Therapy for Advanced MelanomaTerminatedNCT01585415Phase 1
• Study of Lymphoma in AsiaCompletedNCT01584141
• The Ultrasound Study of TamoxifenCompletedNCT01582074
• Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01578109Phase 1
• Imaging Studies and the Development of Multiple MyelomaWithdrawnNCT01571726Phase 2
• Imetelstat for Children With Refractory or Recurrent Solid Tumors and LymphomaWithdrawnNCT01568632Phase 1
• Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaCompletedNCT01567709Phase 1
• Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal ProteinsCompletedNCT01563874
• Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid TumorsActive, not recruitingNCT01552356Phase 1
• Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT01548482Phase 1
• Studying Blood Toxicity in Workers Exposed to FormaldehydeCompletedNCT01547858
• Cancer Symptom Data From Multiple Treatment CentersCompletedNCT01547845
• Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System TumorsCompletedNCT01538095Phase 1
• FdCyd and THU for Advanced Solid TumorsCompletedNCT01534598Phase 1
• Viral Therapy in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01533194Phase 1
• HPV Vaccine Effectiveness in Partially Vaccinated Girls in UgandaCompletedNCT01520272
• Initial Study of Gallbladder Cancer in ChileCompletedNCT01520259
• Testing a Spanish Version of a Patient Toxicity QuestionnaireCompletedNCT01517152
• Diet and Nutrition Pilot Study for Chinese Adolescents and Their MothersCompletedNCT01517139
• Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy ParticipantsCompletedNCT01497431Phase 1
• Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney CancerActive, not recruitingNCT01480154Phase 1
• Providing Access to Cord Blood Units for TransplantsWithdrawnNCT01479582Phase 2
• The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive IrradiationCompletedNCT01468883Phase 3
• AZD7451 for Recurrent GliomasCompletedNCT01468324Phase 1
• Intestine Bacteria and Breast Cancer RiskCompletedNCT01461070
• Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
• Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic CancerTerminatedNCT01457131Phase 1
• Tabectedin to Treat Children and Adolescents With CancerCompletedNCT01453283Phase 1
• Vitamin D Levels in the Skin of Healthy Subjects After Oral SupplementationCompletedNCT01447355Phase 1
• ABT-888 Plus Metronomic Cyclophosphamide to Treat CancerCompletedNCT01445522Phase 1
• Dasatinib in Combination With Bevacizumab to Treat Advanced Solid TumorsCompletedNCT01445509Phase 1
• Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain MetastasesCompletedNCT01445483
• AZD2281 Plus Carboplatin to Treat Breast and Ovarian CancerCompletedNCT01445418Phase 1
• Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerCompletedNCT01445405Phase 1
• SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural MesotheliomaTerminatedNCT01445392Phase 1
• Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant CancerCompletedNCT01445379Phase 1
• Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell LymphomaTerminatedNCT01445340Phase 1
• Analysis of Data Collected From Individuals Administered Neurobehavioral AssessmentsCompletedNCT01445314
• Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System TumorsCompletedNCT01445288
• Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation ProceduresCompletedNCT01445158
• An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV InfectionCompletedNCT01445145
• Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell TransplantationCompletedNCT01445132Phase 1
• A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid TumorsCompletedNCT01445106Phase 1
• 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast CancerTerminatedNCT01445054Early Phase 1
• -02341066 and PF-00299804 for Advanced Non-Small Cell Lung CancerTerminatedNCT01441128Phase 1
• Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerCompletedNCT01440998Phase 1
• Breath Test for Chemicals (Volatile Organic Compounds)CompletedNCT01437033
• TKM 080301 for Primary or Secondary Liver CancerCompletedNCT01437007Phase 1
• Veliparib and Dinaciclib in Treating Patients With Advanced Solid TumorsActive, not recruitingNCT01434316Phase 1
• Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab OnlyCompletedNCT01434303Phase 1
• Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib MesylateTerminatedNCT01426334Phase 1
• Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals PatientsCompletedNCT01424878
• Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care TreatmentStatus unknownNCT01421862
• ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney ProblemsWithdrawnNCT01419548Phase 1
• Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk NeuroblastomaCompletedNCT01418495
• NHS-IL12 for Solid TumorsCompletedNCT01417546Phase 1
• MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell LymphomaWithdrawnNCT01415765Phase 1/2
• Amatuximab for High Mesothelin CancersTerminatedNCT01413451Early Phase 1
• Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaCompletedNCT01403415Phase 1
• CT-011 and p53 Genetic Vaccine for Advanced Solid TumorsWithdrawnNCT01386502Phase 1
• Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerCompletedNCT01383343Phase 1
• High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent GliomaTerminatedNCT01378481Phase 1
• Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT01375829Phase 1
• Livestock Contact and MRSA in Rural AreasCompletedNCT01375621
• Resveratrol in Postmenopausal Women With High Body Mass IndexCompletedNCT01370889Phase 1
• Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionActive, not recruitingNCT01366144Phase 1
• Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families StudyCompletedNCT01365975
• Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesActive, not recruitingNCT01364051Phase 1

← National Cancer Institute (NCI) overview and focus areas